Structural basis of ligand recognition and activation of the histamine receptor family.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 06 01 2024
accepted: 12 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

Histamine is a biogenic amine that is critical in various physiological and pathophysiological processes, including but not limited to allergic reactions, wakefulness, gastric acid secretion and neurotransmission. Here, we determine 9 cryo-electron microscopy (cryo-EM) structures of the 4 histamine receptors in complex with four different G protein subtypes, with endogenous or synthetic agonists bound. Inside the ligand pocket, we identify key motifs for the recognition of histamine, the distinct binding orientations of histamine and three subpockets that facilitate the design of specific ligands. In addition, we also identify key residues responsible for the selectivity of immethridine. Moreover, we reveal distinct structural features as determinants of Gq vs. Gs or Gs vs. Gi coupling differences among the histamine receptors. Our study provides a structural framework for understanding the ligand recognition and G protein coupling of all 4 histamine receptors, which may facilitate the rational design of ligands targeting these receptors.

Identifiants

pubmed: 39333117
doi: 10.1038/s41467-024-52585-y
pii: 10.1038/s41467-024-52585-y
doi:

Substances chimiques

Ligands 0
Histamine 820484N8I3
Receptors, Histamine 0
Histamine Agonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8296

Subventions

Organisme : Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology)
ID : 2019YFA0904100

Informations de copyright

© 2024. The Author(s).

Références

Haas, H. L., Sergeeva, O. A. & Selbach, O. Histamine in the nervous system. Physiol. Rev. 88, 1183–1241 (2008).
pubmed: 18626069 doi: 10.1152/physrev.00043.2007
Garbarg, M., Barbin, G., Feger, J. & Schwartz, J. C. Histaminergic pathway in rat-brain evidenced by lesions of medial forebrain-bundle. Science 186, 833–835 (1974).
pubmed: 4157144 doi: 10.1126/science.186.4166.833
Akdis, C. A. & Blaser, K. Histamine in the immune regulation of allergic inflammation. J. Allergy Clin. Immunol. 112, 15–22 (2003).
pubmed: 12847474 doi: 10.1067/mai.2003.1585
Metcalfe, D. D., Baram, D. & Mekori, Y. A. Mast cells. Physiol. Rev. 77, 1033–1079 (1997).
pubmed: 9354811 doi: 10.1152/physrev.1997.77.4.1033
Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14, 478–494 (2014).
pubmed: 24903914 doi: 10.1038/nri3690
Fulkerson, P. C. & Rothenberg, M. E. Targeting eosinophils in allergy, inflammation and beyond. Nat. Rev. Drug Discov. 12, 117–129 (2013).
pubmed: 23334207 doi: 10.1038/nrd3838
Gantz, I. et al. Molecular-cloning of a gene encoding the histamine-H2-receptor. Proc. Natl Acad. Sci. USA 88, 429–433 (1991).
pubmed: 1703298 pmcid: 50824 doi: 10.1073/pnas.88.2.429
Morisset, S. et al. High constitutive activity of native H(3) receptors regulates histamine neurons in brain. Nature 408, 860–864 (2000).
pubmed: 11130725 doi: 10.1038/35048583
Yokoyama, H. The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain. Brain Dev. 23, 542–547 (2001).
pubmed: 11701252 doi: 10.1016/S0387-7604(01)00261-3
Parsons, M. E. & Ganellin, C. R. Histamine and its receptors. Br. J. Pharmacol. 147, S127–S135 (2006).
pubmed: 16402096 pmcid: 1760721 doi: 10.1038/sj.bjp.0706440
Leconiat, M., Traiffort, E., Ruat, M., Arrang, J. M. & Berger, R. Chromosomal localization of the human histamine H-1-receptor gene. Hum. Genet. 94, 186–188 (1994).
doi: 10.1007/BF00202867
Oda, T., Morikawa, N., Saito, Y., Masuho, Y. & Matsumoto, S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275, 36781–36786 (2000).
pubmed: 10973974 doi: 10.1074/jbc.M006480200
Lovenberg, T. W. et al. Cloning and functional expression of the human histamine H-3 receptor. Mol. Pharmacol. 55, 1101–1107 (1999).
pubmed: 10347254 doi: 10.1124/mol.55.6.1101
Thurmond, R. L., Gelfand, E. W. & Dunford, P. J. The role of histamine H-1 and H-4 receptors in allergic inflammation: the search for new antihistamines. Nat. Rev. Drug Discov. 7, 41–53 (2008).
pubmed: 18172439 doi: 10.1038/nrd2465
Panula, P. et al. International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol. Rev. 67, 601–655 (2015).
pubmed: 26084539 pmcid: 4485016 doi: 10.1124/pr.114.010249
Leurs, R., Smit, M. J. & Timmerman, H. Molecular pharmacological aspects of histamine-receptors. Pharmacol. Therap. 66, 413–463 (1995).
doi: 10.1016/0163-7258(95)00006-3
Dauvilliers, Y. et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 12, 1068–1075 (2013).
pubmed: 24107292 doi: 10.1016/S1474-4422(13)70225-4
Simons, F. E. R. Drug therapy - advances in H-1-antihistamines. N. Engl. J. Med. 351, 2203–2217 (2004).
pubmed: 15548781 doi: 10.1056/NEJMra033121
Simons, F. E. R. & Simons, K. J. Histamine and H-1-antihistamines: celebrating a century of progress. J. Allergy Clin. Immunol. 128, 1139 (2011).
pubmed: 22035879 doi: 10.1016/j.jaci.2011.09.005
Hershcovici, T. & Fass, R. Gastro-oesophageal reflux disease beyond proton pump inhibitor therapy. Drugs 71, 2381–2389 (2011).
pubmed: 22117130 doi: 10.2165/11597300-000000000-00000
Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J. & Numans, M. E. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst. Rev. 2013, CD002095 (2013).
pubmed: 23728637 pmcid: 7066537
Nguyen, P. L. & Cho, J. Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets. Biomolecules 11, 1232 (2021).
pubmed: 34439898 pmcid: 8392479 doi: 10.3390/biom11081232
Kimura, S. et al. Relationship between CCL22 expression by vascular smooth muscle cells and macrophage histamine receptors in atherosclerosis. J. Atheroscler. Thromb. 25, 1240–1254 (2018).
pubmed: 29794410 pmcid: 6249366 doi: 10.5551/jat.44297
Cao, J. et al. H(1)R mediates local anesthetic-induced vascular permeability in angioedema. Toxicol. Appl. Pharm. 392, 114921 (2020).
doi: 10.1016/j.taap.2020.114921
Kawakami, N., Miyoshi, K., Horio, S. & Fukui, H. Beta(2)-adrenergic receptor-mediated histamine H(1) receptor down-regulation: another possible advantage of beta(2) agonists in asthmatic therapy. J. Pharm. Sci. 94, 449–458 (2004).
doi: 10.1254/jphs.94.449
Masini, E., Blandina, P., Brunelleschi, S. & Mannaioni, P. F. Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 12, 85–88 (1982).
pubmed: 6177221 doi: 10.1007/BF01965111
Clark, R. A., Gallin, J. I. & Kaplan, A. P. The selective eosinophil chemotactic activity of histamine. J. Exp. Med. 142, 1462–1476 (1975).
pubmed: 450 doi: 10.1084/jem.142.6.1462
Frei, R. et al. Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J. Allergy Clin. Immunol. 132, 194–204 (2013).
pubmed: 23465664 doi: 10.1016/j.jaci.2013.01.013
Mazzoni, A. et al. Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J. Immunol. 170, 2269–2273 (2003).
pubmed: 12594246 doi: 10.4049/jimmunol.170.5.2269
Yuan, H. & Silberstein, S. D. Histamine and migraine. Headache 58, 184–193 (2018).
pubmed: 28862769 doi: 10.1111/head.13164
Del Valle, J. & Gantz, I. Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273, G987–G996 (1997).
pubmed: 9374694
Yoshimoto, R. et al. Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus. Proc. Natl Acad. Sci. USA 103, 13866–13871 (2006).
pubmed: 16954192 pmcid: 1560086 doi: 10.1073/pnas.0506104103
Liu, Y. et al. Visualization of the activation of the histamine H3 receptor (H3R) using novel fluorescence resonance energy transfer biosensors and their potential application to the study of H3R pharmacology. FEBS J. 285, 2319–2336 (2018).
pubmed: 29701013 doi: 10.1111/febs.14484
O’Reilly, M. et al. Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J. Recept Signal Transduct. Res. 22, 431–448 (2002).
pubmed: 12503632 doi: 10.1081/RRS-120014612
Zampeli, E. & Tiligada, E. The role of histamine H4 receptor in immune and inflammatory disorders. Br. J. Pharm. 157, 24–33 (2009).
doi: 10.1111/j.1476-5381.2009.00151.x
Jemima, E. A., Prema, A. & Thangam, E. B. Functional characterization of histamine H4 receptor on human mast cells. Mol. Immunol. 62, 19–28 (2014).
pubmed: 24934979 doi: 10.1016/j.molimm.2014.05.007
Shimamura, T. et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 475, 65–70 (2011).
pubmed: 21697825 pmcid: 3131495 doi: 10.1038/nature10236
Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. 29, 1188–1195 (2022).
pubmed: 36396979 doi: 10.1038/s41594-022-00859-8
Peng, X. et al. Structural basis for recognition of antihistamine drug by human histamine receptor. Nat. Commun. 13, 6105 (2022).
pubmed: 36243875 pmcid: 9569329 doi: 10.1038/s41467-022-33880-y
Im, D. et al. Structural insights into the agonists binding and receptor selectivity of human histamine H(4) receptor. Nat. Commun. 14, 6538 (2023).
pubmed: 37863901 pmcid: 10589313 doi: 10.1038/s41467-023-42260-z
Wang, C. et al. Measurement and control of quasiparticle dynamics in a superconducting qubit. Nat. Commun. 5, 5836 (2014).
pubmed: 25518969 doi: 10.1038/ncomms6836
Xia, R. et al. Structural basis of ligand recognition and design of antihistamines targeting histamine H4 receptor. Nat. Commun. 15, 2493 (2024).
pubmed: 38509098 pmcid: 10954740 doi: 10.1038/s41467-024-46840-5
Xia, R. X. et al. Cryo-EM structure of the human histamine H-1 receptor/G(q) complex. Nat. Commun. 12, 2086 (2021).
pubmed: 33828102 pmcid: 8027608 doi: 10.1038/s41467-021-22427-2
Hua, T. et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547, 468 (2017).
pubmed: 28678776 pmcid: 5793864 doi: 10.1038/nature23272
Carrión-Antolí, A. et al. Antioxidant systems and quality in sweet cherries are improved by preharvest GABA treatments leading to delay postharvest senescence. Int. J. Mol. Sci. 25, 260 (2023).
pubmed: 38203428 pmcid: 10779314 doi: 10.3390/ijms25010260
Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931–942.e18 (2021).
pubmed: 33571431 pmcid: 8215686 doi: 10.1016/j.cell.2021.01.027
Duan, J. et al. Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy. Nat. Commun. 11, 4121 (2020).
pubmed: 32807782 pmcid: 7431577 doi: 10.1038/s41467-020-17933-8
Qi, X. et al. Cryo-EM structure of oxysterol-bound human smoothened coupled to a heterotrimeric Gi. Nature 571, 279–283 (2019).
pubmed: 31168089 pmcid: 6777001 doi: 10.1038/s41586-019-1286-0
Garcia-Nafria, J., Nehme, R., Edwards, P. C. & Tate, C. G. Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go. Nature 558, 620–623 (2018).
pubmed: 29925951 pmcid: 6027989 doi: 10.1038/s41586-018-0241-9
Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574–1588.e19 (2020).
pubmed: 32946782 pmcid: 7593816 doi: 10.1016/j.cell.2020.08.024
Rasmussen, S. G. et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477, 549–555 (2011).
pubmed: 21772288 pmcid: 3184188 doi: 10.1038/nature10361
Koehl, A. et al. Structure of the μ-opioid receptor-Gi protein complex. Nature 558, 547–552 (2018).
pubmed: 29899455 pmcid: 6317904 doi: 10.1038/s41586-018-0219-7
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
pubmed: 26592709 pmcid: 4711343 doi: 10.1016/j.jsb.2015.11.003
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
pubmed: 30412051 pmcid: 6250425 doi: 10.7554/eLife.42166
Mao, C. et al. Unsaturated bond recognition leads to biased signal in a fatty acid receptor. Science 380, eadd6220 (2023).
pubmed: 36862765 doi: 10.1126/science.add6220
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859–1865 (2008).
pubmed: 18351591 doi: 10.1002/jcc.20945
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
pubmed: 27819658 doi: 10.1038/nmeth.4067
Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701–1718 (2005).
pubmed: 16211538 doi: 10.1002/jcc.20291
Xiao, P. et al. Tethered peptide activation mechanism of the adhesion GPCRs ADGRG2 and ADGRG4. Nature 604, 771–778 (2022).
pubmed: 35418677 doi: 10.1038/s41586-022-04590-8
Yang, F. et al. Structure, function and pharmacology of human itch receptor complexes. Nature 600, 164–169 (2021).
pubmed: 34789875 doi: 10.1038/s41586-021-04077-y

Auteurs

Xuan Zhang (X)

Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China. xuz56@pitt.edu.
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261, USA. xuz56@pitt.edu.

Guibing Liu (G)

Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.

Ya-Ni Zhong (YN)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Ru Zhang (R)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Chuan-Cheng Yang (CC)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Canyang Niu (C)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Xuanyu Pu (X)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
School of Pharmacy, Binzhou Medical University, Yantai, Shandong, 264003, China.

Jingjing Sun (J)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Tianyao Zhang (T)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Lejin Yang (L)

Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Department of Psychology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.

Chao Zhang (C)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Xiu Li (X)

Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.

Xinyuan Shen (X)

Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.

Peng Xiao (P)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China. pengxiao@sdu.edu.cn.

Jin-Peng Sun (JP)

Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo college of Medicine, Shandong University, Jinan, Shandong, 250012, China. sunjinpeng@sdu.edu.cn.
Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. sunjinpeng@sdu.edu.cn.
NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. sunjinpeng@sdu.edu.cn.
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, China. sunjinpeng@sdu.edu.cn.

Weimin Gong (W)

Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China. wgong@ustc.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH